BioSpace News Archive

Otitis externa causes inflammation of the external ear canal, which is a tube between ear and eardrum. The inflammation is caused due to infection in the ear canal which can be bacterial or fungal origin.

A chemical peel is a kind of skin treatment performed to aesthetically improve the structure of a tissue by the topical application of some acidic solution.

In recent months, there is a striking increase in the spread of COVID-19 infection in all worldwide locations. As a result, there is remarkable increase in the number of tests performed for the detection of COVID-19.

The global healthcare systems are undergoing a vibrant change, where patient centric are replacing conventional reactive care model consistently.

Neurosurgery is the procedure of diagnosis and treatment of neurological disorders, such as, Alzheimer’s disease, Parkinson’s disease, strokes, aneurysms, degenerative diseases, and trauma to the spinal cord and brain.

Idorsia Ltd announced that nine abstracts for daridorexant, the company’s investigational dual orexin receptor antagonist for the treatment of adults with insomnia, will be presented at SLEEP 2021.

Fact MR: The global next generation sequencing market is forecast to surpass valuation of US$ 4 billion by end of 2031.

Ambulatory care, also known as outpatient care, is medical care provided on an outpatient basis, including observation, consultation, diagnosis, rehabilitation, intervention, and treatment services.

A novel treatment, a digital therapeutics software solution for Chronic Pain, has shown statistically significant benefit over passive control and standard care interventions for fear of movement, patient clinical global impression of change and quality of life in adult patients with chronic low back pain.

MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. announced clinical data from a Phase 1b study of zandelisib, an investigational selective phosphatidylinositol 3-kinase delta inhibitor in clinical development for the treatment of B-cell malignancies, and the trial design of COASTAL, a Phase 3 study of zandelisib in combination with rituximab, will be highlighted in poster presentations at the 16th International Conference on Malignant Lymphoma to be held June 18 – 22, 2021.